Hint mode is switched on Switch off
For swift navigation between sections

Oculis Holding
LEI 5067005370C2KK324336

PDF download

Choose all Reset all
Download Cancel
Organization name
Oculis Holding AG
Country name
Switzerland
Country of registration
Switzerland
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Oculis Holding AG operates as a biopharmaceutical company. The Company provides eye care treatments for ophthalmology such as retina, dry eye, and neuro ophtha diseases. Oculis Holding serves patients worldwide.

Awards

News

02/06/2026 Oculis Holding AG (NASDAQ:OCS) Price Target Cut Amidst Clinical Trial Setback
All organization news

Documentation

IFRS/US GAAP reports

2025
IV q eng
2024
IV q eng
2023
IV q eng
2022
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    5067005370C2KK324336
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001953530
  • UID
    CHE396695611
Registration is required to get access.